CIK 0001736243 · <br>Emerging growth company
Acurx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ACXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-533-1469
- Business address
- 259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
- Former names
- Acurx Pharmaceuticals, LLC
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- RW Other RW
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
- 8-K Event Results of operations
- S-1 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise Director acquired 19,737 shares (option exercise)
- 4 Option exercise Director acquired 19,737 shares (option exercise)
- 4 Option exercise President and CEO acquired 19,737 shares (option exercise)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Results of operations
Page 7 of 13 · 246 filings